The Velri resource.
Plain-English, citation-backed guides on the goals our members care about. Educational, not medical advice.
Comparing Telehealth Options as a Skeptical Engineer: What Separates Coordinated Care From a Quick Script
A claim-clean look at how coordinated, physician-led telehealth differs from fast-script models on oversight, lab depth, and follow-up.
Read · 7 min →
Diffuse Thinning at the Crown of Your Ponytail: The Labs and Hormone Shifts a Provider Reviews in Perimenopause
What an independent provider may review—thyroid, ferritin, hormones—when evaluating diffuse hair thinning during perimenopause.
Read · 7 min →
Reconnecting After Menopause: The Myths About Desire and Intimacy a Provider Sees Most Often
An educational look at common myths about desire and intimacy after menopause, and what an independent provider actually evaluates.
Read · 7 min →
Daily Confidence Back in the Marriage: How a Provider Weighs Lifestyle Factors Alongside Libido Support
A plain-English look at how sleep, stress, alcohol, and heart health interact with sexual performance — and what a provider reviews alongside any support.
Read · 7 min →
Estrogen, DHEA, and Desire: What a Provider Reviews Before Intimacy Support After Menopause
How an independent provider evaluates desire and comfort changes after menopause — biomarkers, local vs. systemic approaches, and safety.
Read · 8 min →
Microdosing GLP-1 in Maintenance: The Lifestyle Habits a Provider Watches Alongside Your Dose
How protein, resistance training, sleep, and weigh-in cadence interact with a maintenance GLP-1 plan, and what a provider monitors.
Read · 8 min →
Compounded vs. Brand-Name GLP-1: What to Actually Ask Before Your First Script
A claim-clean look at what compounded and brand-name GLP-1 medications mean, the quality questions worth asking, and how coordinated care fits.
Read · 7 min →
Estradiol, Heart, and Bone: The Menopause Biomarkers a Provider Watches When You Refuse to Just Tough It Out
A claim-clean guide to the hormonal, cardiovascular, and bone markers a provider may review when considering menopause symptom support.
Read · 8 min →
Founder-Mom on Empty: How a Provider Separates Iron, Thyroid, and B-Vitamin Causes of Postpartum Fatigue
An educational look at the fatigue biomarkers a provider reviews postpartum—ferritin, TSH, free T4, B12, and folate—before anything else.
Read · 6 min →
Irregular Cycles and Stubborn Belly Weight: Why a Provider May Look at GLP-1 and PCOS Markers Together
How insulin, androgens, and cycle irregularity interact—and what a provider may review when weight and hormonal markers overlap.
Read · 7 min →
Newly Engaged and Tired at 34: How Enclomiphene and TRT Differ When Fertility Still Matters
A decision-stage look at how enclomiphene and testosterone therapy differ in mechanism and what providers review around fertility.
Read · 7 min →
Brain Fog, Mood Swings, and Insomnia at 43: How a Provider Sorts Neuroendocrine Perimenopause Symptoms From Everyday Stress
An educational look at the neuroendocrine side of perimenopause and how a provider separates hormone-driven symptoms from stress or thyroid issues.
Read · 7 min →
The Truth About Your Numbers: What a Hands-On Guy Should Expect From a First Telehealth Checkup
A plain-English look at how a telehealth baseline works, the core markers it flags, and what bloodwork alone can't tell you yet.
Read · 7 min →
Finally Getting Your Own Labs Done: A Caregiver's Guide to What a First Baseline Panel Actually Measures
A plain-English walkthrough of what a first telehealth baseline panel measures and why caregivers deserve their own bloodwork.
Read · 7 min →
Tried the Pills With No Luck: What a Provider Checks in Non-Responders
An educational look at the labs and underlying factors a provider reviews when first-line oral options for ED stop working.
Read · 7 min →
Optimizing Every System at 53: How a Physician-Led Plan Prioritizes Which Biomarkers to Move First
How a physician sequences a longevity workup—prioritizing high-leverage biomarkers instead of chasing dozens at once.
Read · 7 min →
Self-Employed and Can't Afford a Slow Gear: How a Provider Separates Fixable Fatigue From Burnout
A plain-English look at the energy and metabolic biomarkers a provider reviews to tell correctable fatigue from stress and lifestyle.
Read · 7 min →
Optimizing the Right Way, Not Broscience: The Hormone Biomarkers a Provider Tracks for Competitive Trainers
An educational look at the hormone and supporting biomarkers an independent provider reviews for athletes—and why oversight differs from self-directed protocols.
Read · 7 min →
Injuries That Won't Fully Heal: How a Provider Weighs Recovery Peptides vs. Wait-and-Rehab
An educational, claim-clean look at how a physician-led plan evaluates recovery-focused options against structured rehab and conservative care.
Read · 7 min →
Worried Peptides Aren't FDA Approved? How a Cautious Newcomer Should Evaluate Oversight and Quality
A plain-language guide to what 'not FDA approved' really signals, how pharmacy oversight works, and the questions worth asking.
Read · 7 min →
When Desire Quietly Fades in Midlife: What a Provider Reviews Before Suggesting Support for Women
How a provider untangles hormonal, relational, medication, and thyroid contributors to low desire in midlife women — the conversation and labs that come first.
Read · 7 min →
Done Guessing About Your Body: What a First Telehealth Baseline Panel Covers (and What It Won't Tell You Yet)
A plain-English walkthrough of what a starter baseline lab panel covers, why providers sequence tests, and how to read results without over-reacting.
Read · 7 min →
Rebuilding Your Baseline After a Year of Sleep Loss: The Energy Biomarkers a Provider Reviews Postpartum
An educational look at the labs a provider reviews to separate normal postpartum recovery from something treatable — and what NAD+ curiosity does and doesn't address.
Read · 7 min →
Early Menopause at 38: The Myths That Delay Care and What the Evidence Actually Says
An evidence-based look at early and surgical menopause: the myths that delay care and what changes when onset comes sooner.
Read · 7 min →
Spontaneity Back in the Marriage: How a Provider Approaches Daily vs. As-Needed Libido Support
An educational look at how providers compare daily and as-needed approaches to ED support, what they review first, and what the conversation involves.
Read · 6 min →
Needle-Averse and Postpartum: Comparing Oral and Injectable GLP-1 Formats for a New Mom's First Step
An educational look at how providers weigh oral versus injectable GLP-1 formats, and the safety questions worth raising at a first consult.
Read · 8 min →
Scared of the Shower Drain: The Postpartum Hair Shedding Timeline and the Labs a Provider Checks
A calm, educational guide to postpartum hair shedding, when it warrants a closer look, and the labs an independent provider may review.
Read · 7 min →
Guarding the Hairline You Still Have: What a Provider Reviews Before Starting Early Prevention
How an independent provider assesses a stable-but-receding hairline, what they rule out, and what early-prevention monitoring looks like.
Read · 7 min →
The Strongest Option, Done Right: What a Results-Driven Owner Should Ask Before Starting Dual-Action GLP-1
An educational look at the labs, safety checkpoints, and coordinated care a provider reviews before considering dual-action GLP-1 therapy.
Read · 7 min →
Reclaiming Vitality After 56: The Myths About Menopause Symptom Support, Corrected
An educational look at common menopause-support misconceptions, the evolving science, and what an independent provider actually evaluates.
Read · 7 min →
Stalled on Semaglutide: What a Provider Reviews Before Considering a Switch to Dual-Action
How an independent provider investigates a weight-loss plateau before deciding whether a switch to tirzepatide makes sense for you.
Read · 6 min →
Caregiver Burnout and the Energy Biomarkers a Provider Reviews When You're Running on Empty for Everyone Else
For the caregiver running on empty: what a provider may review beyond 'you're just tired' — thyroid, iron, B12, vitamin D, and stress.
Read · 7 min →
Already Tracking Everything: What a Physician Adds to a Biohacker's Self-Quantified Longevity Data
How coordinated, physician-led review interprets wearable and at-home data alongside clinical biomarkers — and where DIY tracking has blind spots.
Read · 7 min →
Two Years on Fumes: How a Provider Tells Low Testosterone From Burnout in Dads in Their 40s
How a provider separates burnout from low testosterone using sleep, cortisol, lifestyle, and the biomarkers reviewed before any hormone conversation.
Read · 7 min →
Performance Anxiety, Not Just Plumbing: How a Provider Approaches Young Men's Sexual Health
Why sexual performance issues in healthy men are often stress-driven, what a provider reviews, and when labs make sense.
Read · 7 min →
The Crown in the Mirror: How Providers Stage Male Hair Loss and What They Rule Out First
A plain-English look at how providers stage male pattern hair loss, the labs and scalp signs they review, and what they rule out first.
Read · 7 min →
Blindsided by Perimenopause at 43: The Symptoms, the Hormone Shifts, and the Labs a Provider Orders
A mechanism-and-biomarker guide to perimenopause symptoms, the hormone changes behind them, and the labs a provider reviews.
Read · 7 min →
TRT and Fertility: What a Provider Reviews Before You Start (If You Still Want Kids)
An educational look at how testosterone therapy can affect fertility, why providers weigh fertility-sparing options, and the biomarkers reviewed first.
Read · 7 min →
Carrying Weight and Running on Empty: How a Provider Looks at Metabolic Fatigue Together
How a coordinated review can examine the biomarkers behind stubborn weight and the fatigue picture together, instead of as two separate problems.
Read · 7 min →
Ready for a Real Medical Weight Option: What Happens at Your First GLP-1 Consult
A plain-English walkthrough of a first GLP-1 telehealth consult: the questions, the labs, and what early care looks like.
Read · 7 min →
Vaginal Dryness and Lost Desire After Menopause: What a Provider Reviews Before Suggesting Support
An educational look at the physical and hormonal drivers of postmenopausal dryness and low desire, and how providers think about them.
Read · 7 min →
Jet Lag, Cortisol, and the Frequent Flyer: The Energy Biomarkers a Provider Reviews for Road Warriors
How repeated time-zone disruption can show up in cortisol rhythm, ferritin, B12, and thyroid markers — and what an independent provider reviews first.
Read · 7 min →
Beyond a Basic Physical: The Longevity Biomarkers a Physician-Led Plan Actually Reviews
How a comprehensive longevity panel differs from a standard annual checkup, and how an independent physician uses those markers over time.
Read · 7 min →
Postpartum Hair Shedding: The Timeline, the Hormones, and When a Provider Looks Deeper
A plain-English guide to postpartum hair shedding (telogen effluvium): the timeline, the hormones, and the labs a provider may review.
Read · 6 min →
Strength, Bone, and Muscle in Perimenopause: The Biomarkers a Provider Tracks for Women Lifting Through 47
How estradiol, FSH, vitamin D, ferritin, and metabolic markers interact with training and recovery — and what an independent provider reviews.
Read · 7 min →
When the Pills Stop Working: How Providers Reassess Erectile Support Beyond First-Line Options
What a provider actually investigates when oral ED pills stop delivering reliable results, and why 'try a higher dose' isn't always the answer.
Read · 7 min →
Microdosing GLP-1 to Hold Goal Weight: What 'Maintenance' Actually Means and What a Provider Monitors
An educational look at GLP-1 maintenance: what 'microdosing' refers to, the biomarkers providers watch, and why lifestyle still carries the work.
Read · 7 min →
Your First Baseline Panel: The Numbers a Provider Reviews Before Any Plan Begins
A plain-English walkthrough of the foundational labs—metabolic, lipids, A1c, testosterone, thyroid—and what a provider looks for first.
Read · 7 min →
Coordinated Care vs. DIY Stacking: How a Physician-Led Peptide Plan Differs From Self-Sourcing
A claim-clean comparison of self-sourcing peptides versus a physician-led plan with provider oversight, quality sourcing, and biomarker review.
Read · 7 min →
Night-Shift Fatigue and Your Circadian Biomarkers: What a Provider Reviews Beyond 'Get More Sleep'
A plain-English look at the biomarkers an independent provider may review when night-shift work leaves you foggy on your days off.
Read · 7 min →
Perimenopause and Hair Thinning: What's Connected and What a Provider Rules Out
How perimenopause can coincide with diffuse hair thinning, and which biomarkers a provider checks first.
Read · 7 min →
PCOS, Irregular Cycles, and Stubborn Belly Weight: The Biomarkers a Provider Reviews
An educational look at the androgen, insulin, glucose, and lipid markers a provider reviews to understand the metabolic-hormonal picture.
Read · 7 min →
Scared of Needles? What to Know About Oral vs. Injectable GLP-1 Formats
An honest, plain-English look at how oral and injectable GLP-1 medications differ and the questions a provider helps you weigh.
Read · 7 min →
Semaglutide vs. Tirzepatide: How Providers Compare Single- and Dual-Action Options
A claim-clean look at how single- and dual-receptor mechanisms differ and what a provider weighs when a plateau hits.
Read · 6 min →
Insulin Resistance, Explained: The Biomarkers Behind Stubborn Weight
A plain-English look at how insulin resistance develops and the labs a provider reviews to understand your metabolic context.
Read · 6 min →
The Libido Conversation: What a Provider Actually Reviews Before Suggesting Support
How an independent provider separates vascular, hormonal, medication, and psychological contributors to low libido before any plan.
Read · 7 min →
Shedding vs. Thinning: How Providers Tell the Difference and What They Rule Out First
Learn how providers distinguish temporary hair shedding from progressive thinning, and the labs and history reviewed before any treatment conversation.
Read · 6 min →
Enclomiphene vs. Testosterone Therapy: How the Two Approaches Differ
An educational, claim-clean comparison of two approaches to low testosterone: stimulating natural production versus supplementing the hormone directly.
Read · 7 min →
BPC-157: What to Know About the Evidence and Its FDA Status
A plain-language, high-caution look at BPC-157: what the research actually shows (mostly animal studies), what the FDA has said about it and how that status changed in 2026, and why its regulatory picture matters before you consider it.
Read →
Peptides, Explained: What They Are and Where Regulation Stands
A plain-language look at what peptides actually are, the real limits of the human evidence, how regulation is shifting, and why "research-only" peptides bought online carry serious risks.
Read →
The Biomarkers That Matter for Your Goals
A plain-language guide to the core blood panels everyone should know (CBC, CMP, lipids, A1c) and the goal-specific add-ons (ApoB, hsCRP, fasting insulin, testosterone, vitamin D) that show where you really stand, plus why "normal" and "optimal" are not the same thing.
Read →
Perimenopause and Menopause: The Hormone Changes, Explained
A plain-language look at what shifts during perimenopause and menopause, the experiences women often report, and how hormone therapy is discussed with a provider.
Read →
Testosterone Therapy: How It Works and Who It's Considered For
A plain-language look at how testosterone therapy works, who it's considered for, the forms it comes in, and the monitoring and risks a provider weighs before prescribing.
Read →
Low Testosterone in Men: Symptoms and How It's Diagnosed
Low testosterone has many causes and overlapping symptoms. Learn what doctors look for and why diagnosis takes both symptoms and repeat morning blood tests.
Read →
NAD+ and NMN for Energy and Aging: What the Research Actually Shows
An honest look at NAD+ and NMN supplements for energy and aging: what the human studies found, where the evidence is still thin, and why major clinics urge caution.
Read →
GLP-1 Medications: What People Commonly Experience in the First Weeks
A plain-language look at the stomach-related effects people commonly report when starting a GLP-1 medication, why providers raise the dose slowly, and the signs that mean it is time to check in with your care team.
Read →
How GLP-1 Medications Work in the Body
A plain-English look at what GLP-1 is, how it affects appetite and blood sugar, and why whether it fits you is a decision only a licensed provider can make.
Read →
Why a Long-Term Health Goal Needs Steady, Connected Care
Living well for longer is a long game, but most care comes in short, disconnected visits. Here is what the research says about why continuity and coordination matter, and how a connected, non-clinical model is built to support them.
Read →
Is Compounded Medication Safe? The Questions Worth Asking
"Is compounded medication safe?" is the wrong question. Use this plain-language framework — 503A vs 503B, USP standards, state boards, and red flags — to evaluate the pharmacy actually making your medication.
Read →
What "Not FDA Approved" Actually Means for Compounded Medications
A plain-language guide to what compounding is, what FDA approval actually covers, how compounded medications are regulated by state boards and USP, and the questions worth asking before you fill one.
Read →Articles are for general education and are not medical advice. Velri is a non-clinical company; care is provided by independent, licensed providers. Compounded medications are not FDA approved.